These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. [The dilemma of anticoagulant therapy in coronary disease]. Loeliger EA Clin Ter; 1970 Dec; 55(6):493-502. PubMed ID: 5515934 [No Abstract] [Full Text] [Related]
50. Drug therapy review--coumarin and indandione derivatives. Am J Hosp Pharm; 1973 Aug; 30(8):705-13. PubMed ID: 4579074 [No Abstract] [Full Text] [Related]
51. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents]. Gross R Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339 [No Abstract] [Full Text] [Related]
52. [Anticoagulation in transitory ischemic attack after bypass surgery]. Bruhn HD Dtsch Med Wochenschr; 1997 Feb; 122(7):210. PubMed ID: 9072493 [No Abstract] [Full Text] [Related]
54. The use of anticoagulants in the prevention of venous thrombosis after myocardial infarction. Pussell BA; Pitney WR Med J Aust; 1972 Nov; 2(20):1101-3. PubMed ID: 4640563 [No Abstract] [Full Text] [Related]
57. Tissue-type plasminogen activator for acute coronary thrombosis. Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965 [No Abstract] [Full Text] [Related]
58. [A statistical study on 100 cases of myocardial infarct at the acute phase. Influence of anticoagulants on short-term prognosis in patients over 70]. Macrez C; Roche P; Pollet JC; Neukirch F Ann Med Interne (Paris); 1974 Jan; 125(1):1-7. PubMed ID: 4844152 [No Abstract] [Full Text] [Related]
60. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]